Its expression has been associated with advanced tumor [85, 86] and through its interaction with β1-integrin, ILK responds to matrix stiffness activating an ILK/PI3K/Akt pathway, leading to up-regulation of self-renewal capacity in CSCs. This evidence concerns the gene ILK and neoplasm.